2017 annual financial data
Celldex Therapeutics 2017 Net income growth
Direct answer
Net income growth was 27.62%.
Operating income was -121,527,000 USD and net income was -93,031,000 USD.
Operating cash flow was -99,931,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,743,000 USD
- Operating income
- -121,527,000 USD
- Net income
- -93,031,000 USD
- Operating cash flow
- -99,931,000 USD